The case for being bullish on Eastman Chemical Company (NYSE: EMN) can no longer be justified due to contracting volumes and prices across Eastman's business portfolio, according to JPMorgan.
JPMorgan's Jeffrey Zekauskas downgraded Eastman Chemical from Overweight to Neutral with a price target lowered from $88 to $80.
Eastman continues to reduce its internal propylene production by around 330 million pounds to 220 million in 2019 and could replace the shortfall with refinery grade propylene that it could upgrade to polymer grade, Zekauskas wrote in a note. The reduction in activity should put some pressure on the company's valuation over the coming months from the risk of operational shortfalls in a low volume environment.
Granted, the analyst said Eastman's cash flow generation for 2019 could come in at more than $1 billion which is more than 10% of the Eastman share price. This suggests an appealing investment thesis for the longer-term but the near-term outlook is less bullish.
Instead, investors may opt for investing in Celanese Corporation (NYSE: CE) as the company hopes to grow its already "good" margin integrated U.S. operations and better positioning itself against higher cost Asian acetyl production. Celanese also boasts superior financial leverage and a more open view on growth through acquisitions, joint-ventures, marketing arrangements, or even through a transformational transaction.
Shares of Eastman Chemical were trading lower by 0.5% at $77.25 Monday afternoon.
Benzinga's Top Upgrades, Downgrades For July 29, 2019
JPMorgan Downgrades HB Fuller On Volume Headwinds Due To Global Economic Slowdown
Latest Ratings for EMN
View More Analyst Ratings for EMN
View the Latest Analyst Ratings
See more from Benzinga
- MKM On Cabot Oil & Gas: Buy The Dip
- Should Investors Follow Twitter's Stock Near 52-Week Highs? The Street Weighs In
- Stifel On UPS: Wait To Buy This 'Large, Improving Cash Flow Machine'
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.